Synthesis and antifungal activities of some aryl [3-(imidazol-1-yl/triazol-1-ylmethyl) benzofuran-2-yl] ketoximes

European Journal of Medicinal Chemistry

Volumn 41, Issue 5, 2006, Pages 651-656

  Gündoǧdu Karaburun, Nalan ^a   Benkli, Kadriye ^a   Tunali, Yaǧmur ^a   Uçucu, Ümit ^a   Demirayak, Şeref ^a  

^a ANADOLU UNIVERSITY   (Turkey)

Author keywords

Antifungal activity; Aryl 3 (imidazol 1 yl triazol 1 ylmethyl)benzofuran 2 yl ketoximes

Indexed keywords

(3 METHYL BENZOFURAN 2 YL)KETOXIME DERIVATIVE; 3 (IMIDAZOL 1 YL/TRIAZOL 1 YLMETHYL)BENZOFURAN 2 YL KETONE DERIVATIVE; [3 IMIDAZOL 1YL/TRIAZOL 1 YLMETHYL)BENZOFURAN 2 YL]KETOXIME DERIVATIVE; ANTIFUNGAL AGENT; UNCLASSIFIED DRUG; BENZOFURAN; BENZOFURAN DERIVATIVE; IMIDAZOLE; IMIDAZOLE DERIVATIVE; OXIME; PYRROLE DERIVATIVE;

ANTIFUNGAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG STRUCTURE; DRUG SYNTHESIS; INFRARED SPECTROSCOPY; MASS SPECTROMETRY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; CANDIDA; CHEMICAL STRUCTURE; CHEMISTRY; DRUG EFFECT; METHYLATION; STRUCTURE ACTIVITY RELATION; SYNTHESIS;

ANTIFUNGAL AGENTS; AZOLES; BENZOFURANS; CANDIDA; IMIDAZOLES; METHYLATION; MOLECULAR STRUCTURE; OXIMES; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 33746742482     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2005.12.013     Document Type: Article

References (25)

1. Benedetti M.S., and Bani M. Drug Metab. Rev. 31 (1999) 665-717
2. Raga M.M., Moreno-Manas M., Cuberes M.R., Palacin C., Castello J.M., and Ortiz J.A. Arzneimittelforschung 42 (1992) 691-694
3. Massolini G., Carmellino M.L., Kitsos M., and Baruffini A. Farmaco 48 (1993) 503-514
4. Papadaki-Valiraki A., Papakonstantinou-Garoufalias S., Marakos P., Chytyroglou-Lada A., Hosoya M., Balzarini J., and de Clercq E. Farmaco 48 (1993) 1091-1102
5. Massolini G., Carmellino M.L., and Baruffini A. Farmaco 49 (1994) 747-749
6. Foye W.O., Lemke T.L., and Williams D.A. Principles of Medicinal Chemistry, Fourth ed (1995), Williams and Wilkins, London 345-387 (499-534)
7. Massolini G., Carmellino M.L., and Baruffini A. Farmaco 51 (1996) 287-292
8. Papakonstantinou-Garoufalias S., Marakos P., Tsantili-Kakoulidou A., and Chytyroglou-Ladas A. Pharmazie 53 (1998) 300-302
9. Tunçbilek M., Bozdaǧ O., Ayhan-Ki{dotless}lci{dotless}gil G., Altanlar N., Büyükbingöl E., and Ertan R. Arzneimittelforschung 49 (1999) 853-857
10. Karakurt A., Dalkara S., Özalp M., Özbey S., Kendi E., and Stables J.P. Eur. J. Med. Chem. 36 (2001) 421-433
11. Kaneko S., Uchida T., Shibuya S., Honda T., Kawamoto I., Harasaki T., Fukuoka T., and Konosu T. Bioorg. Med. Chem. Lett. 12 (2002) 803-806
12. Serrano-Wu M.H., St. Laurent D.R., Mazzucco C.E., Stickle T.M., Barrett J.F., Vyas D.M., and Balasubramanian B.N. Bioorg. Med. Chem. Lett. 12 (2002) 943-946
13. Emami S., Falahati M., Banifatemi A., Amanlou M., and Shafiee A. Bioorg. Med. Chem. 12 (2004) 3971-3976
14. Emami S., Falahati M., Banifatemi A., and Shafiee A. Bioorg. Med. Chem. 12 (2004) 5881-5889
15. Demirayak S.., Uçucu U.., Benkli K., Gündoǧdu-Karaburun N., Karaburun A.C., Akar D., Karabacak M., and Kiraz N. Farmaco 57 (2002) 609-612
16. Benkli K., Gündoǧdu-Karaburun N., Karaburun A.C., Uçucu U.., Demirayak S.., and Kiraz N. Arch. Pharm. Res. 26 (2003) 202-206
17. Menozzi G., Mosti L., Fossa P., Musiu C., Murgioni C., and La Colla P. Farmaco 56 (2001) 633-640
18. Giordani A., Carera A., Pinciroli V., and Cozzi P. Tetrahedron 8 (1997) 253-263
19. Odds F., Ausma J., Van Gerven F., Woestenborghs F., Meerpoel L., Heeres J., Vanden Bossche H., and Borgers A. Antimicrob. Agents Chemother. 48 (2004) 388-391
20. Prasad R., and Kapoor K. Int. Rev. Cytol. 242 (2005) 215-248
21. Artico M., Costi R., Botta M., Di Santo R., Corelli F., Massa S., Ciacci A., and Manetti F. J. Med. Chem. 45 (2002) 2720-2732
22. Xiao L., Madison V., Chau A.S., Loebenberg D., Palermo R.E., and McNicholas P.M. Antimicrob. Agents Chemother. 48 (2004) 568-574
23. Pestellini V., Giolitti A., Pasqui F., Abelli L., Cutrufo C., De Salvia G., Evangelista S., and Meli A. Eur. J. Med. Chem. 23 (1988) 203-206
24. Sugar A.M. Drug Resist. Updat. 1 (1998) 89-92
25. National Committee for Clinical Laboratory Standards. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts; Approved Standard, Second ed., NCCLS document M27-A2 (2002), Villanova, PA (ISBN 1-56238-469-4)